The Fred Hutchinson Cancer Research Center together with its partners the University of Washington, Seattle Children's Hospital and the Seattle Cancer Consotrium Alliance form the Fred Hutchinsonr/University of Washington Cancer Consortium. The Fred Hutchinson Cancer Research Center attracts preeminent researchers in the field of cancer research and treatment, HIV/AIDS and other diseases. On board on three Nobel Laureates, a MacArthur Fellow, six members of the Institute of Medicine and other award winning physticans and researchers. The Vaccine and Infectious Disease Institute is noteworthy. The Center is located in Seattle, Washington.
Researchers at Fred Hutchinson Cancer Research Center showed about 70 percent of patients with the most common adult leukemia had their tumors shrink or disappear following an experimental chimeric antigen receptor (CAR) ...
12
0
A new study has found that flu evolution within some individuals can hint at the virus's eventual evolutionary course worldwide.
13
0
Among long-term colorectal cancer survivors, use of nonsteroidal anti-inflammatory drugs, or NSAIDs, is associated with about a 25 percent reduction in all-cause mortality, according to new research from Fred Hutchinson Cancer ...
0
0
For an investment of $125 for each year of life gained since the 1950s, the National Cancer Institute-funded SWOG clinical trials program has added 3.34 million years of life for cancer patients in the United States because ...
3
0
The critical component of an experimental vaccine led to an escalating immune response in patients with sarcoma, an indicator of its potential anti-cancer effects.
0
0
A new study published in Cell Host & Microbe led by researchers at Fred Hutchinson Cancer Research Center completely maps all mutations that help the HIV virus evolve away from a single broadly neutralizing antibody, known ...
32
0
By adding an experimental drug to a standard chemotherapy regimen, a subset of patients with metastatic pancreatic cancer had a significantly longer period before the cancer progressed as compared with those who received ...
1
0
As many as 53 percent of cancer patients' Emergency Department visits that do not require admission could be avoided with better symptom management and greater availability of outpatient care tailored to their needs, according ...
1
0
Three out of four patients treated with an experimental combination of three different therapies for the rare skin cancer known as Merkel cell carcinoma are in complete remission following the treatment, according to study ...
1
0
A study from Fred Hutchinson Cancer Research Center that will be presented at the American Society of Clinical Oncology annual meeting on June 5 in Chicago shows that asymptomatic women who have been treated for early-stage ...
0
0
